Pathogenesis of hepatitis B virus‐associated hepatocellular carcinoma
Author:
- 16 September 2007
- journal article
- Published by Wiley in Hepatology Research
- Vol. 37 (s2) , S110-S114
Abstract
Hepatitis B virus (HBV)‐associated hepatocellular carcinoma (HCC) remains the most common form of HCC in large areas of Asia and Africa. It remains common even in some countries where hepatitis C virus (HCV)‐associated HCC has become the predominant form, such as Japan. Integration of HBV in HCC DNA is found at random sites in the host genome in nearly all patients with HBV‐associated HCC. It is not clear how often this integration results in insertional mutagenesis, but previously unknown growth regulating genes and cancer‐associated genes have been found frequently near HBV integration sites in HCC in recent studies. In addition, HBV encodes a transactivating protein, the X protein, which could enable the randomly integrated HBV to alter the function of host genes that are not near the integration site. Mutations at two adjacent codons in HBV (1762T/1764A mutations) within the X gene are frequently found in HCC patients, and may play a role in the mutagenic or transactivational role of HBV in HCC. The presence of cirrhosis in most patients with HBV‐associated HCC, and the presence of mutations in tumor suppressor genes in many, suggests that these are also factors in hepatocarcinogenesis. Few studies have examined the mutations of more than one gene in the same HCC patients. Fewstudies have evaluated the interactions between HBV mutations, host gene mutations, cirrhosis, and other potentially mutagenic stresses at the cellular level, with progression to HCC, and few studies have been conducted to determine whether these changes must accumulate in succession to lead to HCC. The recent availability of rapid sequencing methods and DNA microarray technologies has permitted expression profiling and permutation analysis of an array of genes to explore the pattern and succession of molecular changes leading to HBV‐associated HCC. To date, these methods have been used to show patterns of molecular changes that differ in HBV‐associated HCC (compared to HCV‐associated HCC or to HCC in patients lacking either virus) and patterns that can predict survival (and hence may directly indicate different mechanisms of disease), and may soon make possible a universally accepted clinical classification scheme for HCC.Keywords
This publication has 38 references indexed in Scilit:
- Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomasGut, 2005
- Specific mutations of hepatitis B virus in plasma predict liver cancer developmentProceedings of the National Academy of Sciences, 2004
- Molecular and serological aspects of HBsAg‐negative hepatitis B virus infections in North AmericaJournal of Medical Virology, 2003
- Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, ChinaHepatology, 2002
- High Prevalence of 1762T 1764A Mutations in the Basic Core Promoter of Hepatitis B Virus Isolated From Black Africans With Hepatocellular Carcinoma Compared With Asymptomatic CarriersHepatology, 1999
- HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, ChinaJournal of Medical Virology, 1998
- Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinomaThe Lancet, 1996
- Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues.Proceedings of the National Academy of Sciences, 1990
- Prevalence of Hepatocellular Carcinoma and Relation to Cirrhosis: Comparison of Two Different Cities of the World—Trieste, Italy, and Chiba, JapanHepatology, 1989
- The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma.Genes & Development, 1987